共 8 条
- [1] Disease Activity and Damage Are Not Associated With Increased Levels of Fatigue in Systemic Lupus Erythematosus Patients From a Multiethnic Cohort: LXVII [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1179 - 1186
- [2] AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY DEFINITION OF IMPROVEMENT IN RHEUMATOID-ARTHRITIS [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (06): : 727 - 735
- [3] Novel Evidence-Based Systemic Lupus Erythematosus Responder Index [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1143 - 1151
- [4] Frequency and Determinants of Flare and Persistently Active Disease in Systemic Lupus Erythematosus [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1152 - 1158
- [6] Rituximab and lupus: good in real life, bad in controlled trials. Comment on the article by Lu et al [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1281 - 1282
- [7] A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Belimumab in Patients With Active Systemic Lupus Erythematosus [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1168 - 1178
- [8] The Impact of Flare on Disease Costs of Patients With Systemic Lupus Erythematosus [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1159 - 1167